Study Shows Increased Cancer Survival Rates Among Mice Given CBD
Laboratory mice with pancreatic cancer that were treated with cannabidiol (CBD) in conjunction with chemotherapy lived as much as three times longer than those treated with chemotherapy alone, according to a new study released Monday. CBD is a non-psychoactive substance found in cannabis that shows great promise in the treatment of several serious medical conditions including cancer, anxiety, and chronic pain.
Dr. Marco Falasca is a lead researcher at Queen Mary University of London and Curtin University in Western Australia and one of the study’s authors. He said that plans are being made to explore the potential of using CBD to treat cancer of the pancreas in humans.
“Cannabidiol is already approved for use in clinics [in the UK], which means we can quickly go on to test this in human clinical trials,” said Falasca.
“If we can reproduce these effects in humans, cannabidiol could be in use in cancer clinics almost immediately, compared to having to wait for authorities to approve a new drug,” he added.
Falasca is working with the pharmaceutical company Zelda Therapeutics to study the medicinal uses of cannabis. The company is developing new cannabinoid therapies for chronic and fatal diseases including pancreatic cancer.